Orforglipron
aka LY3502970
GLP-1 / Metabolic
Mechanism
Orforglipron (brand name Foundayo) is Eli Lilly's oral non-peptide small-molecule GLP-1 receptor agonist. Unlike oral semaglutide (Rybelsus), it does not require the SNAC absorption enhancer or fasting/water restrictions — it can be taken any time of day. Not a peptide.
Identification
Vendors selling Orforglipron
No vendor listings on file yet.
Research
No citations on file yet.